SECURITIES AND EXCHANGE COMMISSION

 

 

 

Washington, D.C. 20549

 

 

FORM 8-K

CURRENT REPORT

 

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

 

Date of Report (date of earliest event reported):

May 6, 2004

 

 

 

HARVARD BIOSCIENCE, INC.

(Exact Name of Registrant as specified in its charter)

 

 

 

 

 

 

84 October Hill Road, Holliston, MA 01746-1371

(Address of principal executive offices and zip code)

 

(508) 893-8999

(Registrant’s telephone number, including area code)

 

 

ITEM 7.      EXHIBITS

 

(c)                Exhibits.  The following exhibits are being furnished herewith:

 

Exhibit Number		Title
99.1		Press release of Harvard Bioscience, Inc. issued on May 6, 2004

 

 

ITEM 12.    RESULTS OF OPERATIONS AND FINANCIAL CONDITION

 

On May 6, 2004, Harvard Bioscience, Inc. issued a press release announcing its financial results for the quarter ended March 31, 2004.  Copies of Harvard Bioscience, Inc.’s press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

 

 

[Remainder of page intentionally left blank]

 

 

2

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Dated:	May 6, 2004		HARVARD BIOSCIENCE, INC.
			By:	/s/ Susan M. Luscinski
				Susan M. Luscinski
				Chief Financial Officer

 

 

3

 

EXHIBIT INDEX

 

 

Exhibit Number		Title
99.1		Press release of Harvard Bioscience, Inc. issued on May 6, 2004

 

 

4